Adjuvant SOX chemotherapy versus concurrent chemoradiotherapy after D2 radical resection of locally advanced esophagogastric junction (EGJ) adenocarcinoma: study protocol for a randomized phase III trial (ARTEG)

Peer Review reports

Original Submission
19 Oct 2020	Submitted	Original manuscript
24 Jun 2021	Reviewed	Reviewer Report - Muslim Syed
15 Aug 2021	Author responded	Author comments - Jinwen Shen
Resubmission - Version 2
15 Aug 2021	Submitted	Manuscript version 2
20 Aug 2021	Reviewed	Reviewer Report - Muslim Syed
10 Sep 2021	Reviewed	Reviewer Report - Emily V Dressler
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
13 Sep 2021	Editorially accepted
30 Oct 2021	Article published	10.1186/s13063-021-05617-7

Back to article page